Stock · Healthcare
MRK Merck & Co., Inc.
Merck & Co., Inc. has a solid dividend profile with no major red flags in the snapshot data.
Why we rate it 7.0
- Yield of 2.23% is in the typical sustainable zone (2-4%)
- Payout ratio of 269% — dividend exceeds reported earnings, sustainability questionable without growth
- Current yield is below the 5-year average (3.01%), often a sign that price has appreciated faster than dividend growth
- Mega-cap scale (>$200B) — market dominance reduces dividend pressure
Where MRK ranks
We compute the same 0–10 safety score across 53 dividend-paying stocks and ETFs. Here's where MRK lands inside that universe.
The universe is curated to the most-searched US dividend payers. We'll expand it as the data layer grows; sector percentiles only appear when we have at least 5 comparable peers.
The two questions a safety score doesn't answer
A safety score tells you how durable MRK's payout looks. It does not tell you what you keep after tax, or whether something else does the same job better.
On tax: what you actually pocket depends on whether MRK dividends are qualified — qualified distributions are taxed at 0%, 15%, or 20%, while ordinary ones are taxed at your full marginal rate, a gap that can reach 22 percentage points of the income on the same headline yield.
On substitutes: if MRK's 7.0/10 score is lower than you want, see MRK alternatives — same-sector stocks ranked by how closely they match MRK on both yield and safety, so you can see what a swap actually costs you.
About Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
How we score dividend safety
The Infnits dividend safety score is a 0–10 rating derived from yield zone, payout ratio (when applicable), yield trend versus 5-year average, instrument type, and company size. Each factor is independently transparent — see the reasons above for exactly which factors contributed to MRK's score.
For the full methodology including the in-app version that uses ETF look-through and historical cut data, see our methodology page.
This is educational, not investment advice. Dividend safety scores reflect a snapshot of public data on the "as of" date shown. Verify current data on the issuer's investor relations page or your brokerage before making decisions.
Frequently asked questions
Is MRK safe?
On dividend safety specifically, Infnits scores MRK 7/10 — solid. Merck & Co., Inc. has a solid dividend profile with no major red flags in the snapshot data. That score measures how durable the payout looks based on yield zone, payout ratio, yield trend, and instrument type; it does not measure price risk, valuation, or whether MRK suits your portfolio.
Is MRK's dividend safe?
Based on snapshot data — yield 2.23%, payout ratio 269%, instrument type stock — Infnits rates MRK's dividend safety profile as solid (7/10). This is one signal, not a recommendation.
What is MRK's current dividend yield?
MRK has a current dividend yield of 2.23% as of August 24, 2026. Its 5-year average yield is 3.01%.
How is MRK's safety score calculated?
The score combines yield zone (yields above 7% historically carry elevated cut risk), payout ratio (lower is safer), trend vs. 5-year average yield, instrument type (ETFs are inherently more diversified), and size (larger companies have more stable cash flows). Each factor is scored 0-2.5 and summed to a 0-10 result.
Where does this data come from?
Fundamentals are sourced from public market data and refreshed regularly. The "as of" date on each page reflects the snapshot used for the score. For real-time data, check the issuer's investor relations page or your brokerage.
Should I buy MRK based on this score?
No — this is an educational score based on a handful of public signals, not investment advice. Use it as one input among many. For a portfolio-aware analysis with ETF look-through and personalized insights, install the Infnits app.
Get emailed when MRK score changes.
MRK head-to-head comparisons
See MRK compared side-by-side with the most-searched peer tickers — yield, safety, growth trend, expense ratio, and tax treatment.
More MRK analysis
Other dividend tickers
See how MRK fits your portfolio
Add your other holdings and the free analyzer shows your total annual income, weighted safety score, and whether MRK is carrying too much of your income. Runs in your browser — no account, no download.
Or read how safety scoring works.